Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

ClinicalTrials.gov ID: NCT00111618

Public ClinicalTrials.gov record NCT00111618. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 2:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label, Randomized, Phase II Study of AS1404 in Combination With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to confirm a safe dose of AS1404, to be given with docetaxel, and to see whether adding AS1404 and docetaxel together improves the outcome of the treatment, when compared to docetaxel alone.

Study identification

NCT ID
NCT00111618
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Antisoma Research
Industry
Enrollment
70 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2005 (Type not available)
Primary completion
Jun 2007 (Actual)
Completion
Aug 2008 (Actual)
Last update posted
Jan 30, 2009

2005 – 2008

United States locations

U.S. sites
27
U.S. states
12
U.S. cities
26
Facility City State ZIP Site status
Central Hematology Oncology Medical Group Inc Alhambra California 91801 —
Comprehensive Blood and Cancer Center Bakersfield California 93309 —
Providence Saint Joseph's Medical Center (PSJMC) Burbank California 91505 —
Pacific Oncology & Hematology Associates Encinitas California 92024 —
Virginia K. Crosson Cancer Center Fullerton California 92835 —
Pacific Shores Medical Group Long Beach California 90813-3244 —
UCLA Clinical Research Unit Los Angeles California 90095 —
North Valley Hematology/Oncology Medical Group, The Thomas and Dorothy Leavey Cancer Center Northridge California 91328 —
Ventura County Hematology-Oncology Specialists Oxnard California 93030 —
Cancer Care Associates Medical Group, Inc Redondo Beach California 90277 —
Sansum Santa Barbara Medical Foundation Clinic Santa Barbara California 93105 —
Santa Barbara Hematology Oncology Medical Group, Inc. Santa Barbara California 93105 —
Central Coast Medical Oncology Corporation Santa Maria California 93454 —
Stanford University Medical Center-Cancer Center Stanford California 94305 —
University of Miami School of Medicine Miami Florida 33136 —
Peachtree Hematology and Oncology Atlanta Georgia 30309 —
Oncology Hematology Associates of Central Illinois,PC Peoria Illinois 61615 —
Ochsner Cancer Institute New Orleans Louisiana 70121 —
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231-1000 —
Park Nicollet Institute Saint Louis Park Minnesota 55416 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89109 —
Columbia University Medical Center New York New York 10032 —
Staten Island Urological Research Staten Island New York 10304 —
Biomedical Research Alliance of New York (BRANY) The Bronx New York 10461 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
University of Virginia Health System Charlottesville Virginia 22908 —
Marshfield Clinic Foundation Marshfield Wisconsin 54449 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00111618, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2009 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00111618 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →